Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

37.07
Delayed Data
As of 9:39am ET
 +0.09 / +0.24%
Today’s Change
30.70
Today|||52-Week Range
63.20
-13.73%
Year-to-Date
Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away?
9:09am / Zacks.com - Paid Partner Content
New Strong Buy Stocks for August 22nd
Aug 22 / Zacks.com - Paid Partner Content
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close36.98
Today’s open36.93
Day’s range37.07 - 37.07
Volume704
Average volume (3 months)43,780
Market cap$259.3M
Dividend yield--
Data as of 9:39am ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+100.00%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+61.61%
P/E ratio24.9
Price/Sales13.74
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...+0.13+1.81%
SNMXSenomyx Inc+0.07+1.56%
RGNXRegenxbio Inc-0.23-1.87%
CDXSCodexis Inc-0.03-0.71%
Data as of 10:13am ET, 08/29/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.41
Annual revenue (last year)$22.8M
Annual profit (last year)$9.6M
Net profit margin42.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas L. Wegman
Controller
James Goris
Corporate headquarters
Lynbrook, New York

Forecasts

Partner Offers

Search for Jobs